Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Commercially Available Implantable Spacers, in Prostate Cancer Patients Undergoing Radiotherapy

NCT05354427 is registered in ClinicalTrials.gov with BioProtect as lead sponsor.

NCT NCT05354427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05354427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Commercially Available Implantable Spacers, in Prostate Cancer Patients Undergoing Radiotherapy
Lead sponsor
BioProtect
Phase
Observational
Overall status
Completed
Start date
June 18, 2020
Completion date
January 1, 2022
Enrollment
175 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer